Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials

A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo